Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy

Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elena V. Filatova, Natalia S. Krylova, Ivan N. Vlasov, Maria S. Maslova, Natalia G. Poteshkina, Petr A. Slominsky, Maria I. Shadrina
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2e3c0cb32a2d42dabacb2b2e3626ff14
record_format dspace
spelling oai:doaj.org-article:2e3c0cb32a2d42dabacb2b2e3626ff142021-11-21T19:38:53ZTargeted exome analysis of Russian patients with hypertrophic cardiomyopathy2324-926910.1002/mgg3.1808https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff142021-11-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1808https://doaj.org/toc/2324-9269Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. Methods The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. Results The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. Conclusions The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM.Elena V. FilatovaNatalia S. KrylovaIvan N. VlasovMaria S. MaslovaNatalia G. PoteshkinaPetr A. SlominskyMaria I. ShadrinaWileyarticleexomegeneticshypertrophic cardiomyopathynext generation sequencingpathogenic variantsGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 11, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic exome
genetics
hypertrophic cardiomyopathy
next generation sequencing
pathogenic variants
Genetics
QH426-470
spellingShingle exome
genetics
hypertrophic cardiomyopathy
next generation sequencing
pathogenic variants
Genetics
QH426-470
Elena V. Filatova
Natalia S. Krylova
Ivan N. Vlasov
Maria S. Maslova
Natalia G. Poteshkina
Petr A. Slominsky
Maria I. Shadrina
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
description Abstract Background Hypertrophic cardiomyopathy (HCM), described as the presence of hypertrophy of left ventricular, is the most prevalent heritable cardiovascular disease with predominantly an autosomal dominant type of inheritance. However, pathogenic alleles are not identified in at least 25% of patients with HCM, and the spectrum of pathogenic variants that contribute to the development of HCM in Russia has not been fully described. Therefore, the goal of our study was to identify genetic variants associated with the etiopathogenesis of HCM in Russian patients. Methods The study cohort included 98 unrelated adult patients with HCM. We performed targeted exome sequencing, an analysis using various algorithms for prediction of the impact of variants on protein structure and the prediction of pathogenicity using ACMG Guidelines. Results The frequency of pathogenic and likely pathogenic variants in all HCM‐related genes was 8% in our patients. We also identified 20 variants of uncertain significance in all HCM‐related genes. Conclusions The prevalence of individual pathogenic variants in HCM‐related genes in Russian population appears to be lower than in general European population, which could be explained by ethnic features of Russian population, age characteristics of our sample, or unidentified pathogenic variants in genes previously not linked with HCM.
format article
author Elena V. Filatova
Natalia S. Krylova
Ivan N. Vlasov
Maria S. Maslova
Natalia G. Poteshkina
Petr A. Slominsky
Maria I. Shadrina
author_facet Elena V. Filatova
Natalia S. Krylova
Ivan N. Vlasov
Maria S. Maslova
Natalia G. Poteshkina
Petr A. Slominsky
Maria I. Shadrina
author_sort Elena V. Filatova
title Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_short Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_full Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_fullStr Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_full_unstemmed Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
title_sort targeted exome analysis of russian patients with hypertrophic cardiomyopathy
publisher Wiley
publishDate 2021
url https://doaj.org/article/2e3c0cb32a2d42dabacb2b2e3626ff14
work_keys_str_mv AT elenavfilatova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT nataliaskrylova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT ivannvlasov targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT mariasmaslova targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT nataliagpoteshkina targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT petraslominsky targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
AT mariaishadrina targetedexomeanalysisofrussianpatientswithhypertrophiccardiomyopathy
_version_ 1718418692548591616